Adjuvant chemotherapy for medulloblastoma
- PMID: 4027871
- DOI: 10.1002/1097-0142(19850915)56:6<1316::aid-cncr2820560616>3.0.co;2-d
Adjuvant chemotherapy for medulloblastoma
Abstract
The use of adjuvant chemotherapy for cerebellar medulloblastoma is controversial. Twenty-one children and adolescents were treated with adjuvant low-dose cyclophosphamide and vincristine following surgery and radiotherapy. With a mean observation period of 6 years, the disease-free survival is 81%.